Cynapsus reports Q2 results


Cynapsus Therapeutics (OTCQX:CYNAF) Q2 results: Revenues: $0; Net Loss: ($2.8M) (-189.4%); Quick Assets: $20.6M (+801.5%).

Awarded $500K from Michael J. Fox Foundation for Parkinson's Research on July 8, 2014.

No financial guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs